October 13, 2008 – At TCT 2008, Boston Scientific Corp. announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1 and 2 registries, which are designed to confirm the performance of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System in real-world practice.

October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE trial, only two patients required repeat procedures – a 1.5 percent rate of target lesion revascularization (TLR) – at two years following implant, according to data released today at TCT 2008.

There were no instances of stent thrombosis among the 130 study subjects – all of whom received an Endeavor Resolute DES – through 24 months of follow-up.

October 13, 2008 - GE Healthcare and Boston Scientific Corp. agreed to collaborate to improve intravascular ultrasound (IVUS) workflow between the GE Healthcare Innova Cardiovascular X-ray System and the Boston Scientific iLab Ultrasound Imaging System.

Boston Scientific and GE will offer advances in the field of IVUS to joint customers, and are displaying the iLab and Innova Systems at the Oct. 12-17 Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium in Washington, D.C.

October 10, 2008 - A recent study published in the October issue of Journal of Neuroimaging showed CT angiography (CTA) to be an effective, cost-saving alternative to standard catheter angiography for confirmation of internal carotid artery (ICA) occlusions.

The study was conducted by researchers with the University of Michigan’s Stroke Program.

October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System and the company plans to launch the stent early next month in the U.S.

October 10, 2008 - TeraRecon Inc. this weekend will release new innovations in its flagship Aquarius iNtuition platform, to be showcased Oct. 12-17 at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in Washington, D.C.

October 8, 2008 – To evaluate patient safety and quality care benefits of medical devices that share data with EMRs, HIMSS Analytics and the American College of Clinical Engineering have agreed to jointly conduct an ongoing research study of medical devices in American hospitals.

October 9, 2008 – Endosense this week launched the TOCCATA (TOuCh for CATheter Ablation) clinical study to evaluate the safety of the TactiCath system for the treatment of atrial arrhythmias, with enrollment gaining momentum.

TOCCATA is a 70 patient European multi-center safety study. Constructed to gain the CE mark for the treatment of atrial arrhythmias, secondary endpoints were designed to evaluate the value of force-sensing in successfully impacting outcomes of the ablation procedure.

October 9, 2008 - Datascope Corp. said today it will sponsor a 300-patient, randomized clinical trial in high-risk acute myocardial infarction (MI) patients who are not in cardiogenic shock to show the efficacy of intra-aortic balloon counterpulsation in reducing infarct size.

October 9, 2008 - Boston Scientific Corp. yesterday said it completed enrollment in the PERSEUS trial, designed to evaluate the company’s third-generation TAXUS Element paclitaxel-eluting coronary stent.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now